News

Filter

Current filters:

ActelionRare diseases

Auxilium and Actelion get Xiaflex approval in Canada

10-07-2012

US company Auxilium Pharmaceuticals (Nasdaq: AUXL) and the Canadian subsidiary of Actelion (SIX: ATLN),…

ActelionAuxilium PharmaceuticalsBiotechnologyNorth AmericaRare diseasesRegulationXiaflex

Actelion drops setipiprant, gets miglustat approval in Japan

04-04-2012

Switzerland-based Actelion Ltd (SIX: ATLN) announced says that it will re-direct its development efforts…

ActelionAsia-PacificBiotechnologyBrazavesInflammatory diseasesMiglustatRare diseasesRegulationResearchsetipiprantZavesca

Auxilium and Actelion partner on Xiaflex

24-02-2012

biotech firm, have entered into a long-term partnership for the development, supply and commercialization…

ActelionAuxilium PharmaceuticalsBiotechnologyLicensingPharmaceuticalRare diseasesXiaflex

Actelion pulls out of Trophos option

13-12-2011

Switzerland-based Actelion (SIX: ATLN), Europe’s biggest biotech company, says that it has decided…

ActelionBiotechnologyLicensingMergers & AcquisitionsolesoximePharmaceuticalRare diseasesTrophos

Back to top